Skip to content

Investigating the effect of topical tranexamic acid on burn wounds

Evaluation of the Effect of Topical Tranexamic Acid on the Bleeding Rate of the Burn Patient’s Wounds after Debridement?A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240228061125N1
Enrollment
80
Registered
2024-03-16
Start date
2024-03-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn wound.

Interventions

Intervention 1: Intervention group: . For the patients in the intervention group, the gauze dressing will be soaked in 500 mg diluted tranexamic acid plus 1 mg norepinephrine diluted in 500 ml 0.9% sa

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: patients between 15-55 years old over than 20 percent surface of body need skin debridement

Exclusion criteria

Exclusion criteria: dont need icu care not to be third grade burn dont have chemical or electrical burn dont have blunt abdominal trauma or head trauma dont have bleeding disorders dont have thrombotic disorders or hypercoagulopathy dont be post partum or pregnant Hypersensitivity to tranexamic acid Systolic blood pressure higher than 200 mmHg Disruption of coagulation factors Have disturbances in kidney function tests

Design outcomes

Primary

MeasureTime frame
Hemoglobin level. Timepoint: Complete blood count test before operation and 24 hours after operation. Method of measurement: Complete blood count test through the patient's blood sample.;Hematocrit level. Timepoint: Complete blood count test before operation and 24 hours after operation. Method of measurement: Complete blood count test through the patient's blood sample.

Secondary

MeasureTime frame
Occurrence of possible side effects. Timepoint: From the time the patient arrives to the time of discharge from the hospital. Method of measurement: Investigating the presence of side effects during hospitalization.;Duration of hospital stay. Timepoint: The time of arrival to the departure of the patient from the hospital. Method of measurement: Number of days of hospitalization.;The number of Pack cell received. Timepoint: After surgery. Method of measurement: The number of cell packs.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Esmaielzadeh

Karaj University of Medical Sciences

Tinarahimzadeh1390@gmail.com+98 26 3419 7000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026